Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

QL01-26

A Phase II Trial of Olanzapine (Zyprexa) for the Prevention of
Delayed Emesis in Cancer Patients Receiving Chemotherapy

Abstracts/Posters/Presentations:

  • R. M. Navari, L. H. Einhorn, P. J. Loehrer, S. D. Passik, J. Vinson, M. L. Mayer, W. Pletcher, J. McClean. A Phase II Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients Receiving Chemotherapy: Hoosier Oncology Group QL01-26. Presented as a poster discussion at the ASCO annual meeting June 5-8, 2004, New Orleans, LA. J Clin Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 8046

Manuscripts/Articles:

  • Rudolph M. Navari, Lawrence H. Einhorn, Steven D. Passik, Patrick J. Loehrer Sr., Cynthia Johnson, M. L. Mayer, J. McClean, Jake Vinson, W. Pletcher; A Phase II Trial of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Hoosier Oncology Group Study QL01-26. Support Care Cancer. 2005 Jul;13(7):529-34. Epub 2005 Feb 8. PMID: 15700131